Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities

Sponsor
Federal University of São Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT00492245
Collaborator
(none)
30
1
32
0.9

Study Details

Study Description

Brief Summary

The present study was designed to evaluate the treatment of adenoviral corneal opacities with PTK and mitomycin C.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PTK with mitomycin in Adenoviral Opacities
N/A

Detailed Description

Epidemic keratoconjunctivitis is a very common disease, some patients developed a complication after the infection wich is corneal infiltration. Topical treatment sometimes helps to avoid loss of visual acuity. Therefore recurrence of the opacities after topical drops is observed. When corneal fibrosis occur is difficult to achieve visual rehabilitation with topical approach. This study evaluate pre and postoperative data of patients with subepithelial fibrosis caused by adenoviral infiltrates submitted to phototherapeutic keratectomy (PTK) using mitomycin C.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phototherapeutic Keratectomy With Mitomycin C in Adenoviral Infiltrates
Study Start Date :
Apr 1, 2006
Primary Completion Date :
May 1, 2008
Anticipated Study Completion Date :
Dec 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Refractive data, visual acuity, slit lamp findings, subjective evaluation, topography patterns, pachymetry measurements. [one year]

Secondary Outcome Measures

  1. wavefront analysis, anterior segment tomography data, corneal biomechanics data. [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • visual acuity worse than 20/40, caused by central subepithelial fibrosis
Exclusion Criteria:
  • pregnancy, age less than 18 years-old or more than 80 years-old.

  • diabetes, autoimmune diseases, corneal thickness less tha 400 micron.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Federal University of Sao Paulo Sao Paulo Brazil 04145020

Sponsors and Collaborators

  • Federal University of São Paulo

Investigators

  • Principal Investigator: Ester S Yamazaki, MD, Federal University of Sao Paulo - Brazil
  • Study Chair: Mauro S Campos, MD, Federal University of Sao Paulo - Brazil

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00492245
Other Study ID Numbers:
  • CEP0075/06
First Posted:
Jun 27, 2007
Last Update Posted:
Aug 4, 2008
Last Verified:
Jul 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2008